Cargando…

Effects of insulin and the glucagon‐like peptide 1 receptor agonist liraglutide on the kidney proteome in db/db mice

Diabetes mellitus (DM) is a worldwide disease that affects 9% of the adult world population and type 2 DM accounts for 90% of those. A common consequence of DM is kidney complications, which could lead to kidney failure. We studied the potential effects of treatment with insulin and the glucagon‐lik...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liljedahl, Leena, Norlin, Jenny, McGuire, James N., James, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371560/ https://www.ncbi.nlm.nih.gov/pubmed/28330952 http://dx.doi.org/10.14814/phy2.13187

Ejemplares similares

The impact of the glucagon‐like peptide 1 receptor agonist liraglutide on the streptozotocin‐induced diabetic mouse kidney proteome
por: Liljedahl, Leena, et al.
Publicado: (2019)

N-glycosylation proteome enrichment analysis in kidney reveals differences between diabetic mouse models
por: Liljedahl, Leena, et al.
Publicado: (2016)

Liraglutide attenuates hepatic iron levels and ferroptosis in db/db mice
por: Song, Ji-Xian, et al.
Publicado: (2022)

Comparative Study of Liraglutide and Insulin Glargine on Glycemic Control and Pancreatic β-Cell Function in db/db Mice
por: Li, Yanli, et al.
Publicado: (2018)

Glucagon-Like Peptide-1 Receptor Agonist Liraglutide Ameliorates the Development of Periodontitis
por: Sawada, Noritaka, et al.
Publicado: (2020)

Effects of E2HSA, a Long-Acting Glucagon Like Peptide-1 Receptor Agonist, on Glycemic Control and Beta Cell Function in Spontaneous Diabetic db/db Mice
por: Hou, Shaocong, et al.
Publicado: (2015)

ProteomicsDB
por: Schmidt, Tobias, et al.
Publicado: (2018)

Liraglutide reduces lipogenetic signals in visceral adipose of db/db mice with AMPK activation and Akt suppression
por: Shao, Yimin, et al.
Publicado: (2015)

Effects of liraglutide on astrocyte polarization and neuroinflammation in db/db mice: focus on iron overload and oxidative stress
por: An, Ji-Ren, et al.
Publicado: (2023)

The glucagon‐like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents
por: Vallöf, Daniel, et al.
Publicado: (2015)

Kazak faecal microbiota transplantation induces short-chain fatty acids that promote glucagon-like peptide-1 secretion by regulating gut microbiota in db/db mice
por: Han, Xue, et al.
Publicado: (2021)

Effect of Ezetimibe on Insulin Secretion in db/db Diabetic Mice
por: Zhong, Yong, et al.
Publicado: (2012)

Comparative Proteomic Analysis of Liver Tissues and Serum in db/db Mice
por: Zhang, Yu, et al.
Publicado: (2022)

The Global Transcriptional Response of Isolated Human Islets of Langerhans to Glucagon-Like Peptide-1 Receptor Agonist Liraglutide
por: Zhao, Xiaoning, et al.
Publicado: (2012)

Growth hormone-releasing hormone agonist attenuates vascular calcification in diabetic db/db mice
por: Ren, Hao-Lin, et al.
Publicado: (2023)

Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice
por: Udayappan, Shanthadevi, et al.
Publicado: (2016)

Glucagon-like peptide-1 receptor agonist Liraglutide has anabolic bone effects in ovariectomized rats without diabetes.
por: Lu, Nan, et al.
Publicado: (2015)

Glucagon-like peptide-1 receptor agonist, liraglutide, attenuated retinal thickening in spontaneously diabetic Torii fatty rats
por: Inoue, Kazuho, et al.
Publicado: (2022)

Improved postprandial glucose metabolism in type 2 diabetes by the dual glucagon‐like peptide‐1/glucagon receptor agonist SAR425899 in comparison with liraglutide
por: Schiavon, Michele, et al.
Publicado: (2021)

Exercise-like effects by Estrogen-related receptor-gamma in muscle do not prevent insulin resistance in db/db mice
por: Badin, Pierre-Marie, et al.
Publicado: (2016)

Investigation of the Protective Effects of Phlorizin on Diabetic Cardiomyopathy in db/db Mice by Quantitative Proteomics
por: Cai, Qian, et al.
Publicado: (2013)

EGCG-derived polymeric oxidation products enhance insulin sensitivity in db/db mice
por: Wu, Ximing, et al.
Publicado: (2022)

Cosmos DB for MongoDB developers: migrating to Azure Cosmos DB and using the MongoDB API
por: Sharma, Manish
Publicado: (2018)

Jejunal Proteins Secreted by db/db Mice or Insulin-Resistant Humans Impair the Insulin Signaling and Determine Insulin Resistance
por: Salinari, Serenella, et al.
Publicado: (2013)

Proteases in Plasma and Kidney of db/db Mice as Markers of Diabetes-Induced Nephropathy
por: Hadler-Olsen, E., et al.
Publicado: (2011)

Transcriptional Profile of Kidney from Type 2 Diabetic db/db Mice
por: Zhang, Haojun, et al.
Publicado: (2017)

Effects of the glucagon-like peptide-1 receptor agonist liraglutide in juvenile transgenic pigs modeling a pre-diabetic condition
por: Streckel, Elisabeth, et al.
Publicado: (2015)

Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis
por: Meurot, C., et al.
Publicado: (2022)

Liver X receptor agonist treatment attenuates cardiac dysfunction in type 2 diabetic db/db mice
por: He, Qing, et al.
Publicado: (2014)

Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER
por: Shaman, Ahmed M., et al.
Publicado: (2021)

Correction: Jejunal Proteins Secreted by db/db Mice or Insulin-Resistant Humans Impair the Insulin Signaling and Determine Insulin Resistance
por: Salinari, Serenella, et al.
Publicado: (2014)

Disparate phospho-Smad2 levels in advanced type 2 diabetes patients with diabetic nephropathy and early experimental db/db mouse model
por: Thomsen, Lise Høj, et al.
Publicado: (2017)

Perivascular Adipose Tissue Control of Insulin-Induced Vasoreactivity in Muscle Is Impaired in db/db Mice
por: Meijer, Rick I., et al.
Publicado: (2013)

Sargassum coreanum extract alleviates hyperglycemia and improves insulin resistance in db/db diabetic mice
por: Park, Mi Hwa, et al.
Publicado: (2015)

Antidiabetic Effects of Corni Fructus Extract on Blood Glucose and Insulin Resistance in db/db Mice
por: Kim, Hye Jeong, et al.
Publicado: (2009)

Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice
por: Ardaiz, Nuria, et al.
Publicado: (2021)

CERA Attenuates Kidney Fibrogenesis in the db/db Mouse by Influencing the Renal Myofibroblast Generation
por: Fischer, Christin, et al.
Publicado: (2018)

Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: Results of the LEADER and SUSTAIN 6 trials
por: Verma, Subodh, et al.
Publicado: (2020)

The Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Stimulates Mechanistic Target of Rapamycin (mTOR) Signaling via PKA And Akt
por: Le, Thao D V, et al.
Publicado: (2021)

Comparison of the glucagon‐like‐peptide‐1 receptor agonists dulaglutide and liraglutide for the management of diabetes in solid organ transplant: A retrospective study
por: Singh, Priyamvada, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_phbhj9hv5src38nbjcncns8na3